Word: pharma
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Pharma is down, and it may be out. Its problems are not cyclical. As drugs go off patent and fewer "blockbuster" products make it to the market, the future of being in the pharmaceuticals business may be as much about cutting costs as it is R&D. Drug companies don't have any buoyancy. If the stock market has to count on them, the rally is going to be hindered...
...recent op-ed called “Harvard as Big Pharma,” published on Mar. 1, outlined good reasons for Harvard’s involvement with private pharmaceutical companies. It demonstrated a vital engagement with the national conversation about the best means to ensure global access—particularly in the developing world—to the fruits of medical research performed within the academic community. This was accompanied by a call to deliver essential medicines to the developing world at a symposium held at Harvard Law School this week. Harvard should maintain momentum in its quest...
...wall of Sir Michael Rawlins' office in London is a cartoon of a group of men in suits cowering below a giant circular pill inscribed with the word pharma. Amid the supplicants strides an impervious figure from Britain's National Institute for Health and Clinical Excellence (NICE) with a puzzled look on his face. Like the man in the cartoon, NICE head Rawlins doesn't see why drug companies should deserve any deference. His organization uses hard-nosed cost-effectiveness reviews to decide which treatments Britain's National Health Service (NHS) should pay for. A new drug doesn't just...
Roche recently bought Genentech (DNA), a company in which it was already the largest shareholder. That deal was not just about firing. Biotech operations like Genentech are the next generation of pharma companies. Roche wants in on that action. It had the tremendous advantage of only having to buy part of the shares in Genentech. Aside from getting customers and new products, Roche got control of the whole company and merely had to acquire 44% of the shares...
...banning certain types of gifts to doctors and requiring the industry to disclose any others over $50 in value. Harvard has convened a 19-member committee made up of representatives of its medical school, affiliated teaching hospitals and research institutes, and the student body to review its pharma policy, though the university is hedging on whether it actually plans to change the way it operates. "We cannot speculate on the outcomes of the review process" is all a spokesman is willing to say. And as of Wednesday, Pfizer had apologized to Grassley for what it called the "unfortunate incident" that...